Cyprotex plc Company Profile (LON:CRX)

About Cyprotex plc

Cyprotex plc logoCyprotex PLC is a holding company. The Company and its subsidiaries are engaged in the provision of in vitro and in silico Absorption, Distribution, Metabolism, Excretion, Toxicity (ADMET) and Pharmacokinetic (PK) information to the pharmaceutical and biotechnology industries. It offers a range of different services in the areas of ADME-PK, in vitro toxicology, biosciences, in silico prediction, in vitro skin and ocular testing, endocrine disruption and physicochemical profiling. Its in vitro ADME and drug metabolism and pharmacokinetics (DMPK) services include in vitro metabolism, in vitro permeability and transporters, solubility and physicochemical properties, in vitro protein binding and PK and bioanalysis. It operates mainly in North America, Mainland Europe and the United Kingdom. It serves pharmaceutical, biotech, cosmetics, personal care, household products, chemical, agrochemical and tobacco markets. Its subsidiaries include Cyprotex Discovery Limited and Cyprotex US, LLC.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CRX
  • CUSIP:
Key Metrics:
  • Previous Close: $2.00
  • 50 Day Moving Average: $158.05
  • 200 Day Moving Average: $139.40
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for Cyprotex plc (LON:CRX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cyprotex plc (LON:CRX)
Show:
DateFirmActionRatingPrice TargetDetails
11/17/2015N+1 SingerReiterated RatingcorporateView Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Cyprotex plc (LON:CRX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Cyprotex plc (LON:CRX)
Current Year EPS Consensus Estimate: $6.40 EPS

Dividends

Dividend History for Cyprotex plc (LON:CRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cyprotex plc (LON:CRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Cyprotex plc (LON:CRX)
DateHeadline
prnewswire.com logoBrown Gibbons Lang and Company (BGL) Advises in the Sale of Preclinical ADME-Toxicology Services Provider ... - PR Newswire (press release) (LON:CRX)
www.prnewswire.com - January 11 at 9:59 PM
finance.yahoo.com logoBrown Gibbons Lang and Company (BGL) Advises in the Sale of Preclinical ADME-Toxicology Services Provider Cyprotex PLC (LON:CRX)
finance.yahoo.com - January 11 at 4:57 PM
News IconCyprotex Plc CRX Medical Equipment Deals and Alliances Profile Prices from USD $250 (LON:CRX)
www.bioportfolio.com - January 6 at 9:58 PM
publicnow.com logoRecommended Acquisition of Cyprotex PLC by Evotec A.G.Scheme of Arrangement becomes effective & Cancellation of trading of Cyprotex Shares (LON:CRX)
www.publicnow.com - December 21 at 5:19 PM
News IconEVOTEC SCHLIESST AKQUISITION DER CYPROTEX PLC AB - DGAP (Pressemitteilung) (LON:CRX)
www.dgap.de - December 17 at 9:48 PM
finance.yahoo.com logoEvotec Completes Acquisition of Cyprotex PLC - Yahoo Finance (LON:CRX)
finance.yahoo.com - December 17 at 9:48 PM
uk.finance.yahoo.com logoEvotec Completes Acquisition of Cyprotex PLC (LON:CRX)
uk.finance.yahoo.com - December 15 at 3:38 AM
News IconIndicators in Focus on Cyprotex plc (AIM:CRX) - The Business Journal (LON:CRX)
belmontbusinessjournal.com - December 14 at 3:13 AM
trustnet.com logoLaunch of in vitro h-CLAT Service (LON:CRX)
www.trustnet.com - November 30 at 9:53 AM
News IconCyprotex Plc CRX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (LON:CRX)
www.bioportfolio.com - November 18 at 1:41 PM
News IconCyprotex Plc CRX Financial and Strategic SWOT Analysis Review Prices from USD $125 (LON:CRX)
www.bioportfolio.com - November 17 at 9:49 AM
publicnow.com logoRecommended Aquisition of Cyprotex PLC - Posting of Scheme Document & Expected Timetable of Principal Events (LON:CRX)
www.publicnow.com - November 4 at 1:35 PM
publicnow.com logoCircular to Shareholders & Explanatory Statement under section 897 of the Companies Act 2006-Notice of Court & General Meetings (LON:CRX)
www.publicnow.com - November 4 at 1:35 PM
News IconEvotec plans to acquire UK-based CRO, Cyprotex (LON:CRX)
www.pharmabiz.com - October 28 at 6:50 AM
News IconRICHARD SNELLER - Form 8.3 - Cyprotex Plc - Amendment (LON:CRX)
www.advfn.com - October 27 at 4:45 PM
News IconDGAP-Adhoc: Evotec AG announces its intent to acquire Cyprotex PLC (LON:CRX)
www.moneyspecial.de - October 26 at 9:02 AM
rttnews.com logoCyprotex To Be Bought By Germany's Evotec For GBP 41.70 Mln Cash - Quick Facts (LON:CRX)
www.rttnews.com - October 26 at 9:02 AM
businesswire.com logoEvotec AG Announces Its Intent to Acquire Cyprotex PLC (LON:CRX)
www.businesswire.com - October 26 at 9:02 AM
trustnet.com logoCyprotex PLC (CRX) (LON:CRX)
www.trustnet.com - October 22 at 8:42 AM
trustnet.com logoConversion of Loan Notes & TVR (LON:CRX)
www.trustnet.com - October 7 at 9:23 AM
ft.com logoAppointment of new Director of US Operations (LON:CRX)
announce.ft.com - September 26 at 9:12 AM
publicnow.com logoCyprotex extends is metabolite identification service (LON:CRX)
www.publicnow.com - September 13 at 9:16 AM
publicnow.com logoCyprotex extends its metabolite identification service to support human clinical samples (LON:CRX)
www.publicnow.com - September 13 at 9:16 AM
live-pr.com logoNew Report Available: Cyprotex Plc (CRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (LON:CRX)
www.live-pr.com - September 8 at 4:19 PM
live-pr.com logoNew Report Available: Cyprotex Plc (CRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (LON:CRX)
www.live-pr.com - September 8 at 4:19 PM
trustnet.com logoExpansion ADME capabilities (8 transporter assays) (LON:CRX)
www.trustnet.com - September 8 at 4:19 PM
trustnet.com logoExpansion ADME capabilities (8 transporter assays) (LON:CRX)
www.trustnet.com - September 8 at 4:19 PM
publicnow.com logoCyprotex expand ADME capabilities with the introduction of 8 additional transporter assays (LON:CRX)
www.publicnow.com - September 8 at 8:12 AM
publicnow.com logoCyprotex install two AB Sciex TripleTOF® 6600 mass spectrometer systems (LON:CRX)
www.publicnow.com - September 7 at 4:32 PM
capitalcube.com logoCyprotex Plc :CRX-GB: Earnings Analysis: For the six months ended June 30, 2016 : August 12, 2016 (LON:CRX)
www.capitalcube.com - August 12 at 10:00 AM
biz.yahoo.com logoHalf Year 2016 Cyprotex PLC Earnings Release - Before Market Open (LON:CRX)
biz.yahoo.com - August 2 at 9:15 AM
4-traders.com logoCyprotex : Launch New Endocrine Disruption Service (LON:CRX)
www.4-traders.com - July 7 at 4:27 PM
publicnow.com logoCyprotex Launch New Endocrine Disruption Service (LON:CRX)
www.publicnow.com - July 7 at 6:01 AM
stockhouse.com logoLaunch of New Endocrine Disruption Service (LON:CRX)
www.stockhouse.com - June 23 at 10:10 AM
publicnow.com logoLaunch of chemTarget for Predicting Biological Target Interaction directly from Chemical Structure (LON:CRX)
www.publicnow.com - June 23 at 6:39 AM
stockhouse.com logoLaunch of chemTarget (LON:CRX)
www.stockhouse.com - June 16 at 9:43 PM
4-traders.com logoCyprotex : Purchase New IntelliCyt iQue® Screener for Expansion of Cell-Based Services (LON:CRX)
www.4-traders.com - June 16 at 8:48 AM
publicnow.com logoCyprotex Purchase New IntelliCyt iQue® Screener for Expansion of Cell-Based Services (LON:CRX)
www.publicnow.com - June 16 at 5:49 AM
publicnow.com logoLaunch of New Enhanced Version of chemPK™ Workflow Solution for Predicting Human Pharmacokinetics Directly from Chemical Structure (LON:CRX)
www.publicnow.com - May 20 at 5:23 AM
4-traders.com logoCyprotex : Launch of GLP-Compliant Genotoxicity Services (LON:CRX)
www.4-traders.com - May 17 at 1:59 PM
publicnow.com logoLaunch of GLP-Compliant Genotoxicity Services (LON:CRX)
www.publicnow.com - May 17 at 5:02 AM
proactiveinvestors.co.uk logoRisers & Fallers: Patagonia Gold, ITM Power, Cardiff Property, Sound Energy, Venn Life Sciences, CloudTag (LON:CRX)
www.proactiveinvestors.co.uk - May 10 at 1:37 PM
capitalcube.com logoCyprotex Plc :CRX-GB: Earnings Analysis: For the six months ended December 31, 2015 (LON:CRX)
www.capitalcube.com - April 5 at 2:17 PM
capitalcube.com logoCyprotex Plc :CRX-GB: Earnings Analysis: 2015 By the Numbers (LON:CRX)
www.capitalcube.com - April 5 at 1:49 PM
uk.finance.yahoo.com logoForm 8.3 - Cyprotex Plc (LON:CRX)
uk.finance.yahoo.com - April 4 at 7:36 AM
trustnet.com logoLaunch of Advanced 3D Liver Model (LON:CRX)
www.trustnet.com - March 31 at 12:36 PM
4-traders.com logoCyprotex : Launch of New Chemical and Cosmetics Testing Guide (LON:CRX)
www.4-traders.com - March 31 at 12:36 PM
uk.finance.yahoo.com logoCyprotex unveils new 3D liver model (LON:CRX)
uk.finance.yahoo.com - March 31 at 12:27 PM
trustnet.com logoLaunch of New Chemical and Cosmetics Testing Guide (LON:CRX)
www.trustnet.com - March 9 at 11:44 AM
noodls.com logoCyprotex launch Short Time Exposure service for identifying potential serious eye damage for new chemicals (LON:CRX)
www.noodls.com - March 19 at 5:25 AM

Social

What is Cyprotex plc's stock symbol?

Cyprotex plc trades on the London Stock Exchange (LON) under the ticker symbol "CRX."

When will Cyprotex plc announce their earnings?

Cyprotex plc is scheduled to release their next quarterly earnings announcement on Tuesday, August, 2nd 2016.

How do I buy Cyprotex plc stock?

Shares of Cyprotex plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Cyprotex plc stock cost?

One share of Cyprotex plc stock can currently be purchased for approximately GBX 160.50.


Last Updated on 2/25/2017 by MarketBeat.com Staff